Eirion to Present Update on Its Neuromodulator Product Candidates at The Medical Aesthetic Injectable Summit 2024October 1, 2024 – Woburn, MA – Eirion Therapeutics Inc., a biopharmaceutical company focused on developing innovative aesthetic prescription product offerings, announced today that successful results had been achieved in its Phase 1 – 2 clinical trial for the treatment of moderate to severe glabellar wrinkles using its next generation, ready-to-use liquid injectable neuromodulator AI-